Governance
Board of Directors
Independent oversight is not optional for a company that moves customer funds. Three of five seats are independent. The charter, attendance and recusals are published every year.
Composition
Five seats — three independent
Independent Chair
Since 2025
Former CFO of a NYSE-listed marketing software company. 18 years in B2B SaaS finance. Chairs the Audit committee.
Committees: Audit · Nominating
Founder · CEO
Since 2024
Operating founder. Voting member; recuses from compensation matters. 12 years across performance marketing and fintech.
Independent Director
Since 2025
Former General Counsel at an EU payments licensee. Leads the Risk & Compliance committee. Member of two other private boards.
Committees: Risk · Audit
Independent Director
Since 2026
CISO at a top-10 European bank. Chairs Risk & Compliance, member of the Audit committee.
Committees: Risk
Investor Director
Since 2025
Partner at our lead investor. Voting member with carve-outs around portfolio-level conflicts.
Committees: Nominating · Compensation
Names are withheld at director request until each member opts in publicly. Verified backgrounds are available under NDA via /procurement.
Committees
Standing committees
Audit
Oversight of financial reporting, external auditor relationship, internal controls (SOX-like), whistleblower channel.
Quarterly · 6 sessions in 2026
Chair: Independent Chair
Risk & Compliance
Information security, AML/KYC posture, AI governance per EU AI Act, vendor risk, business continuity.
Monthly · 11 sessions in 2026
Chair: Independent Director (CISO)
Nominating & Compensation
Director succession, executive compensation, equity refresh pool, founder vesting acceleration.
Bi-annual · 2 sessions in 2026
Chair: Independent Chair
Attendance
2026 attendance log
| Meeting | Date | Attendance | Notes |
|---|---|---|---|
| Q1 Board | 2026-02-04 | 5/5 | Reviewed FY25 audit, approved 2026 plan. |
| Q2 Board | 2026-05-13 | 5/5 | Approved enterprise term sheet template; passed AI use policy. |
| Q3 Board | 2026-08-20 | 4/5 (1 recusal) | Conflict logged on a portfolio-overlap topic; investor director recused. |
Conflict-of-interest policy
Directors disclose every related-party interest at appointment and re-confirm quarterly. Conflicts trigger automatic recusal and are recorded in the minutes. Investor directors are excluded from votes on competing portfolio companies and from compensation matters affecting their fund's economics.